Analytical Chemistry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 20, 2024
Patients
with
epidermal
growth
factor
receptor
mutant
nonsmall
cell
lung
cancer
(NSCLC)
often
fail
to
treat
gefitinib
because
of
secondary
drug
resistance.
The
development
tumor
resistance
is
closely
related
variations
in
metabolism.
Single-cell
metabolomics
analysis
can
provide
unique
information
about
Herein,
we
constructed
a
platform
study
the
cells
based
on
single-cell
(sSRTC-scM).
A
gefitinib-resistant
NSCLC
line
(PC9GR)
was
by
increasing
dose
step
step.
metabolic
profiles
parental
PC9
and
PC9GR
different
levels
were
detected
intact
living-cell
electrolaunching
ionization
mass
spectrometry
at
level.
data
analyzed
statistical
methods
such
as
t-SNE,
variance,
volcano
plot,
heat
map,
pathway
analysis.
Using
this
platform,
found
that
fingerprints
evaluate
degrees.
continue
be
altered
increase
We
revealed
19
markers
variance
clarified
glycerophospholipid
changed
significantly.
In
addition,
levels,
heterogeneity
metabolism
became
greater
number
weak
gradually
decreased.
This
phenomenon
utilized
illustrate
degrees
cells.
provides
diagnostic
for
evaluating
tumors
gives
new
insight
into
overcoming
tumors.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
13
Published: Jan. 18, 2023
Ovarian
cancer
is
a
malignant
tumor
of
the
female
reproductive
system,
with
very
poor
prognosis
and
high
mortality
rates.
Chemotherapy
radiotherapy
are
most
common
treatments
for
ovarian
cancer,
unsatisfactory
results.
Exosomes
subpopulation
extracellular
vesicles,
which
have
diameter
approximately
30–100
nm
secreted
by
many
different
types
cells
in
various
body
fluids.
highly
stable
effective
carriers
immunotherapeutic
drugs.
Recent
studies
shown
that
exosomes
involved
cellular
responses
microenvironment,
influencing
development
therapeutic
efficacy
exhibiting
dual
roles
inhibiting
promoting
development.
also
contain
variety
genes
related
to
immunotherapy
could
be
potential
biomarkers
diagnosis
prognosis.
Undoubtedly,
great
field
immunotherapy.
However,
translation
this
idea
clinic
has
not
occurred.
Therefore,
it
important
understand
how
used
regulate
progression.
In
review,
we
summarize
fluids
mechanisms
influence
response.
We
discuss
prospects
clinical
application
exosome-based
cancer.
Small,
Journal Year:
2024,
Volume and Issue:
20(26)
Published: March 14, 2024
Abstract
Single‐cell
mass
spectrometry
(MS)
is
significant
in
biochemical
analysis
and
holds
great
potential
biomedical
applications.
Efficient
sample
preparation
like
sorting
(i.e.,
separating
target
cells
from
the
mixed
population)
desalting
moving
off
non‐volatile
salt
solution)
urgently
required
single‐cell
MS.
However,
traditional
methods
suffer
complicated
operation
with
various
apparatus,
or
insufficient
performance.
Herein,
a
one‐step
strategy
by
leveraging
label‐free
impedance
flow
cytometry
(IFC)
based
microfluidics
proposed.
Specifically,
IFC
framework
to
characterize
sort
single‐cells
adopted.
Simultaneously
sorting,
cell
transferred
local
high‐salinity
buffer
MS‐compatible
solution.
In
this
way,
are
achieved
collected
can
be
directly
fed
for
MS
analysis.
A
high
efficiency
(>99%),
cancer
purity
(≈87%),
whole
workflow
of
impedance‐based
separation
normal
(MCF‐10A)
(MDA‐MB‐468)
verified.
As
standalone
module,
microfluidic
chip
compatible
variety
methods,
envisioned
provide
new
paradigm
efficient
preparation,
further
multi‐modal
electrical
metabolic)
characterization
single‐cells.
Chemical Science,
Journal Year:
2022,
Volume and Issue:
13(27), P. 8065 - 8073
Published: Jan. 1, 2022
While
single-cell
mass
spectrometry
can
reveal
cellular
heterogeneity
and
the
molecular
mechanisms
of
intracellular
biochemical
reactions,
its
application
is
limited
by
insufficient
detection
sensitivity
resulting
from
matrix
interference
sample
dilution.
Herein,
we
propose
an
intact
living-cell
electrolaunching
ionization
(ILCEI-MS)
method.
A
capillary
emitter
with
a
narrow-bore,
constant-inner-diameter
ensures
that
entire
living
cell
enters
MS
ion-transfer
tube.
Inlet
improves
utilization,
no
solvent
required,
preventing
dilution
interference.
Based
on
these
features,
greatly
improved,
average
signal-to-noise
(S/N)
ratio
about
20
:
1
peaks
in
TIC
ILCEI-MS.
high
throughput
51
cells
per
min
was
achieved
ILCEI-MS
for
metabolic
profiling
multiple
lines,
368
metabolites
were
identified.
Further,
more
than
4000
primary
single
digested
fresh
multi-organ
tissues
mice
detected
ILCEI-MS,
demonstrating
applicability
reliability.
Analytical Chemistry,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 9, 2024
Chemoresistance
to
triple-negative
breast
cancer
(TNBC)
is
a
critical
issue
in
clinical
practice.
Lipid
metabolism
takes
unique
role
cells;
especially,
unsaturated
lipids
involving
cell
membrane
fluidity
and
peroxidation
are
highly
remarked.
At
present,
for
the
lack
of
high-resolution
molecular
recognition
platform
at
single-cell
level,
it
still
hard
systematically
study
chemoresistance
heterogeneity
based
on
lipid
unsaturation
proportion.
By
designing
mass
spectrometry
workflow
CyESI-MS,
we
profiled
TNBC
cells
evaluate
lipidomic
remodeling
under
platinum
stress.
Profiling
revealed
polyunsaturated
proportion
cisplatin
treatment.
A
cluster
identified
by
accumulation
was
found
be
involved
sensitivity.
Furthermore,
that
could
regulated
fatty
acid
supplementation,
which
determinates
composition
lipids.
These
discoveries
provide
insights
monitoring
controlling
cellular
proportions
overcome
cancer.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: May 23, 2024
Abstract
Comprehensive
single-cell
metabolic
profiling
is
critical
for
revealing
phenotypic
heterogeneity
and
elucidating
the
molecular
mechanisms
underlying
biological
processes.
However,
metabolomics
remains
challenging
because
of
limited
metabolite
coverage
inability
to
discriminate
isomers.
Herein,
we
establish
a
platform
in-depth
organic
mass
cytometry.
Extended
analysis
time
guarantees
sufficient
MS/MS
acquisition
identification
isomers
discrimination
while
online
sampling
ensures
high-throughput
method.
The
largest
number
identified
metabolites
(approximately
600)
are
achieved
in
single
cells
fine
subtyping
MCF-7
first
demonstrated
by
an
investigation
on
differential
levels
3-hydroxybutanoic
acid
among
clusters.
Single-cell
transcriptome
reveals
differences
expression
downstream
antioxidative
stress
genes,
such
as
metallothionein
2
(MT2A),
fluorescence-activated
cell
sorting
assay
confirms
positive
relationship
between
target
proteins;
these
results
suggest
that
provides
cancer
with
different
ability
resist
surrounding
oxidative
stress.
Our
method
paves
way
deep
metabolome
investigations
physiological
pathological
processes
occur
during
cancer.
Analytical Chemistry,
Journal Year:
2023,
Volume and Issue:
95(18), P. 7212 - 7219
Published: April 20, 2023
Mass
spectrometry
(MS)
has
become
a
powerful
tool
for
metabolome,
lipidome,
and
proteome
analyses.
The
efficient
analysis
of
multi-omics
in
single
cells,
however,
is
still
challenging
the
manipulation
cells
lack
in-fly
cellular
digestion
extraction
approaches.
Here,
we
present
streamlined
strategy
highly
automatic
single-cell
by
MS.
We
developed
10-pL-level
microwell
chip
housing
individual
whose
proteins
were
found
to
be
digested
5
min,
which
144
times
shorter
than
traditional
bulk
digestion.
Besides,
an
automated
picoliter
system
was
sampling
metabolites,
phospholipids,
tandem
from
same
cell.
Also,
2
min
MS2
spectra
obtained
700
pL
solution
cell
sample.
In
addition,
1391
proteins,
metabolites
detected
one
within
10
min.
further
analyzed
cancer
tissue
samples,
achieving
up
40%
increase
classification
accuracy
using
comparison
with
single-omics
analysis.
This
MS
analyzing
information
investigation
heterogeneity
phenotyping
biomedical
applications.
Analytical Chemistry,
Journal Year:
2023,
Volume and Issue:
95(10), P. 4712 - 4720
Published: March 1, 2023
Studying
the
mechanisms
of
drug
antitumor
activity
at
single-cell
level
can
provide
information
about
responses
cell
subpopulations
to
therapy,
which
is
essential
for
accurate
treatment
cancer.
Due
small
size
single
cells
and
low
contents
metabolites,
metabolomics-based
approaches
studying
action
are
lacking.
Herein,
we
develop
a
label-free
platform
based
on
metabolomics
(sMDA-scM)
by
integrating
intact
living-cell
electro-launching
ionization
mass
spectrometry
(ILCEI-MS)
with
analysis.
Using
this
platform,
reveal
that
non-small-cell
lung
cancer
(NSCLC)
treated
gefitinib
be
clustered
into
two
different
metabolic
responses.
The
glutathione
pathway
subpopulation
containing
14.4%
not
significantly
affected
gefitinib,
exhibiting
certain
resistance
characteristics.
presence
these
masked
judgment
whether
cysteine
methionine
was
remarkably
influenced
in
analysis
overall
average
results,
revealing
heterogeneity
response
NSCLC
treatment.
findings
basis
evaluating
early
therapeutic
effects
clinical
medicines
insights
overcoming
subpopulations.
Analytical Chemistry,
Journal Year:
2024,
Volume and Issue:
96(14), P. 5499 - 5508
Published: March 28, 2024
Characterizing
the
profiles
of
proteome
and
metabolome
at
single-cell
level
is
great
significance
in
multiomic
studies.
Herein,
we
proposed
a
novel
strategy
called
one-shot
analysis
(scPMA)
to
acquire
information
individual
one
injection
LC-MS/MS
analysis.
Based
on
scPMA
strategy,
total
workflow
was
developed
achieve
capture,
nanoliter-scale
sample
pretreatment,
LC
separation
enzyme-digested
peptides
metabolites,
dual-zone
MS/MS
detection
for
profiling.
Benefiting
from
realized
dual-omic
single
tumor
cells,
including
A549,
HeLa,
HepG2
cells
with
816,
578,
293
protein
groups
72,
91,
148
metabolites
quantified
average.
A
perspective
experiment
investigating
doxorubicin-induced
antitumor
effects
both
aspects
also
performed.